1,818 research outputs found
No preferential spatial distribution for massive stars expected from their formation
We analyse N-body and Smoothed Particle Hydrodynamic (SPH) simulations of young star-forming regions to search for differences in the spatial distributions of massive stars compared to lower-mass stars. The competitive accretion theory of massive star formation posits that the most massive stars should sit in deeper potential wells than lower-mass stars. This may be observable in the relative surface density or spatial concentration of the most massive stars compared to other, lower-mass stars. Massive stars in cool–collapse N-body models do end up in significantly deeper potentials, and are mass segregated. However, in models of warm (expanding) star-forming regions, whilst the massive stars do come to be in deeper potentials than average stars, they are not mass segregated. In the purely hydrodynamical SPH simulations, the massive stars do come to reside in deeper potentials, which is due to their runaway growth. However, when photoionisation and stellar winds are implemented in the simulations, these feedback mechanisms regulate the mass of the stars and disrupt the inflow of gas into the clouds’ potential wells. This generally makes the potential wells shallower than in the control runs, and prevents the massive stars from occupying deeper potentials. This in turn results in the most massive stars having a very similar spatial concentration and surface density distribution to lower-mass stars. Whilst massive stars do form via competitive accretion in our simulations, this rarely translates to a different spatial distribution and so any lack of primordial mass segregation in an observed star-forming region does not preclude competitive accretion as a viable formation mechanism for massive stars
Acceleration of the universe, vacuum metamorphosis, and the large-time asymptotic form of the heat kernel
We investigate the possibility that the late acceleration observed in the
rate of expansion of the universe is due to vacuum quantum effects arising in
curved spacetime. The theoretical basis of the vacuum cold dark matter (VCDM),
or vacuum metamorphosis, cosmological model of Parker and Raval is revisited
and improved. We show, by means of a manifestly nonperturbative approach, how
the infrared behavior of the propagator (related to the large-time asymptotic
form of the heat kernel) of a free scalar field in curved spacetime causes the
vacuum expectation value of its energy-momentum tensor to exhibit a resonance
effect when the scalar curvature R of the spacetime reaches a particular value
related to the mass of the field. we show that the back reaction caused by this
resonance drives the universe through a transition to an accelerating expansion
phase, very much in the same way as originally proposed by Parker and Raval.
Our analysis includes higher derivatives that were neglected in the earlier
analysis, and takes into account the possible runaway solutions that can follow
from these higher-derivative terms. We find that the runaway solutions do not
occur if the universe was described by the usual classical FRW solution prior
to the growth of vacuum energy-density and negative pressure (i.e., vacuum
metamorphosis) that causes the transition to an accelerating expansion of the
universe in this theory.Comment: 33 pages, 3 figures. Submitted to Physical Review D15 (Dec 23, 2003).
v2: 1 reference added. No other change
Polychromatic flow cytometry is more sensitive than microscopy in detecting small monoclonal plasma cell populations
Background
There is an emerging role for flow cytometry (FC) in the assessment of small populations of plasma cells (PC). However, FC's utility has been questioned due to consistent underestimation of the percentage of PC compared to microscopy.
Methods
A retrospective study was performed on bone marrow samples analysed by 8-colour FC. Plasma cell populations were classified as polyclonal or monoclonal based on FC analysis. FC findings were compared with microscopy of aspirates, histology and immunohistochemistry of trephine biopsies, and immunofixation (IFX) of serum and/or urine.
Results
FC underestimated PC compared to aspirate and trephine microscopy. The 10% diagnostic cutoff for MM on aspirate microscopy corresponded to a 3.5% cutoff on FC. Abnormal plasma cell morphology by aspirate microscopy and clonality by FC correlated in 229 of 294 cases (78%). However, in 50 cases, FC demonstrated a monoclonal population but microscopy reported no abnormality. In 15 cases, abnormalities were reported by microscopy but not by FC. Clonality assessment by trephine microscopy and FC agreed in 251/280 cases (90%), but all 29 discordant cases were monoclonal by FC and not monoclonal by microscopy. These cases had fewer PC and proportionally more polyclonal PC, and when IFX detected a paraprotein, it had the same light chain as in the PC determined by FC.
Conclusions
FC was more sensitive in detecting monoclonal populations that were small or accompanied by polyclonal PC. This study supports the inclusion of FC in the evaluation of PC, especially in the assessment of small population
Making things happen : a model of proactive motivation
Being proactive is about making things happen, anticipating and preventing problems, and seizing opportunities. It involves self-initiated efforts to bring about change in the work environment and/or oneself to achieve a different future. The authors develop existing perspectives on this topic by identifying proactivity as a goal-driven process involving both the setting of a proactive goal (proactive goal generation) and striving to achieve that proactive goal (proactive goal striving). The authors identify a range of proactive goals that individuals can pursue in organizations. These vary on two dimensions: the future they aim to bring about (achieving a better personal fit within one’s work environment, improving the organization’s internal functioning, or enhancing the organization’s strategic fit with its environment) and whether the self or situation is being changed. The authors then identify “can do,” “reason to,” and “energized to” motivational states that prompt proactive goal generation and sustain goal striving. Can do motivation arises from perceptions of self-efficacy, control, and (low) cost. Reason to motivation relates to why someone is proactive, including reasons flowing from intrinsic, integrated, and identified motivation. Energized to motivation refers to activated positive affective states that prompt proactive goal processes. The authors suggest more distal antecedents, including individual differences (e.g., personality, values, knowledge and ability) as well as contextual variations in leadership, work design, and interpersonal climate, that influence the proactive motivational states and thereby boost or inhibit proactive goal processes. Finally, the authors summarize priorities for future researc
Computed tomography chest imaging offers no advantage over chest X-ray in the initial assessment of gestational trophoblastic neoplasia
Background
The International Federation of Gynaecology and Obstetrics (FIGO) score identifies gestational trophoblastic neoplasia (GTN) patients as low- or high-risk of single-agent chemotherapy resistance (SACR). Computed tomography (CT) has greater sensitivity than chest X-ray (CXR) in detecting pulmonary metastases, but effects upon outcomes remain unclear.
Methods
Five hundred and eighty-nine patients underwent both CXR and CT during GTN assessment. Treatment decisions were CXR based. The number of metastases, risk scores, and risk category using CXR versus CT were compared. CT-derived chest assessment was evaluated as impact upon treatment decision compared to patient outcome, incidence of SACR, time-to-normal human chorionic gonadotrophin hormone (TNhCG), and primary chemotherapy resistance (PCR).
Results
Metastasis detection (p < 0.0001) and FIGO score (p = 0.001) were higher using CT versus CXR. CT would have increased FIGO score in 188 (31.9%), with 43 re-classified from low- to high-risk, of whom 23 (53.5%) received curative single-agent chemotherapy. SACR was higher when score (p = 0.044) or risk group (p < 0.0001) changed. Metastases on CXR (p = 0.019) but not CT (p = 0.088) lengthened TNhCG. Logistic regression analysis found no difference between CXR (area under the curve (AUC) = 0.63) versus CT (AUC = 0.64) in predicting PCR.
Conclusions
CT chest would improve the prediction of SACR, but does not influence overall treatment outcome, TNhCG, or prediction of PCR. Lower radiation doses and cost mean ongoing CXR-based assessment is recommended
- …